Large study shows pulsed field ablation technique safe and effective for atrial fibrillation treatment
A groundbreaking study involving over 17,000 patients has demonstrated the safety of pulsed field ablation (PFA) for treating atrial fibrillation. The MANIFEST-17K trial, led by researchers from the Icahn School of Medicine at Mount Sinai, provides compelling evidence that this novel technique avoids many of the complications associated with traditional thermal ablation methods.
